INNOSKEL
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases. InnoSkel is developing treatment options for a group of rare skeletal disorders collectively known as type 2 collagenopathies, the most severe of which is Spondyloepiphyseal Dysplasia congenita (SEDc), the second leading cause of dwarfism worldwide. InnoSkel’s lead gene therapy asset for SEDc has demonstrated good efficacy in proof-of-concept studies. The company’s fundamental mission is ... to improve the lives of patients living with skeletal dysplasia and to answer their unmet needs, keeping their voices at the heart of all they do. InnoSkel is a spin-out of the Institut de Biology Valrose at Inserm, the French National Institute of Health and Medical Research, and is based in Nice, France.
INNOSKEL
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Address:
Valbonne, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.innoskel.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0) 20 3709 5700
Email Addresses:
[email protected]
Total Funding:
20 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt WordPress Content Delivery Network Wordpress Plugins Nginx ReCAPTCHA Contact Form 7 Slider Revolution
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Région Sud Investissement
Région Sud Investissement investment in Series A - Innoskel
Vida Ventures
Vida Ventures investment in Series A - Innoskel
Jeito Capital
Jeito Capital investment in Series A - Innoskel
Turenne Capital
Turenne Capital investment in Series A - Innoskel
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-14 | InnoSkel Appoints Dr Sophie Amsellem-Bosq as Chief Technical Officer |
Official Site Inspections
http://www.innoskel.com
- Host name: vps-e44cc83f.vps.ovh.net
- IP address: 54.38.191.39
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Innoskel"
Innoskel - LinkedIn
Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases.See details»
INNOSKEL - The Chandler Project
Innoskel is a pioneering bioscience platform company developing transformative therapies for the unmet needs of individuals with rare bone disorders.1 In December 2020, it was announced …See details»
Innoskel Company Profile 2024: Valuation, Funding & Investors
Operator of a biotechnology company intended to develop transformative therapies for a group of rare skeletal disorders.See details»
Innoskel - The Org
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseasesSee details»
Innoskel - Company Profile & Staff Directory - ContactOut
Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases. Innoskel's first asset is a treatment option for a group of rare skeletal disorders …See details»
Innoskel - Contacts, Employees, Board Members, Advisors & Alumni
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases.See details»
Innoskel - Funding, Financials, Valuation & Investors - Crunchbase
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Innoskel - EU-Startups
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases. The company focuses in developing treatment options for a group of rare skeletal …See details»
InnoSkel awarded Innovation Passport by the UK MHRA for the
Dec 16, 2021 IRDiRC member InnoSkel, a pioneering biotechnology company developing transformative therapies for the unmet needs of individuals with rare bone disorders, …See details»
InnoSkel awarded Innovation Passport by the UK MHRA for the …
Dec 16, 2021 InnoSkel awarded Innovation Passport by the UK MHRA for the treatment of a rare bone disorder First step in the recent UK MHRA initiative to accelerate the development …See details»
Innoskel - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Innoskel . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 9. About. Innoskel is …See details»
InnoSkel Launches with €20 Million Series A Financing - Yahoo …
Dec 14, 2020 InnoSkel Launches with €20 Million Series A Financing Proceeds to support development and advancement of innovative gene therapies for patients with rare skeletal …See details»
InnoSkel Launches with €20 Million Series A Financing
Dec 14, 2020 InnoSkel Launches with €20 Million Series A Financing . Proceeds to support development and advancement of innovative gene therapies for patients with rare skeletal …See details»
INNOSKEL EXPANDS LEADERSHIP TEAM TO ACCELERATE …
May 25, 2021 InnoSkel is a spin-out of the Institut de Biologie Valrose at Inserm, the French National Institute of Health and Medical Research, and is based in Sophia Antipolis, Nice, …See details»
Innoskel - Crunchbase
Organization. Innoskel . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
InnoSkel Launches with 20 Million Series A Financing
InnoSkel is developing treatment options for a group of rare skeletal disorders collectively known as type 2 collagenopathies, the most severe of which is Spondyloepiphyseal Dysplasia …See details»
What is InnoSkel? Company Culture, Mission, Values
See what employees say it's like to work at InnoSkel. Salaries, reviews, and more - all posted by employees working at InnoSkel.See details»
Innoskel - Updates, News, Events, Signals & Triggers - Crunchbase
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases.See details»
INNOSKEL EXPANDS LEADERSHIP TEAM TO ACCELERATE …
May 25, 2021 InnoSkel is a spin-out of the Institut de Biologie Valrose at Inserm, the French National Institute of Health and Medical Research, and is based in Sophia Antipolis, Nice, …See details»